Within the tumor microenvironment (TME) and in chronic inflammatory settings, elevated TGF-β and IL-10 suppress effector T cell activation while expanding Tregs, fostering an immunosuppressive milieu [43]. This evidence concerns the gene TGFB1 and neoplasm.